5 medical device makers crushing the S&P/ASX200

Credit: Brogan & Partners

There’s one industry within one sector that’s absolutely pulverized the S&P/ASX 200 Index (Index: ^AXJO) (ASX: XJO) over the past three months, and you’ll never guess what it is.

These five companies that have all beaten the ASX200 by a minimum 16.8%, and they all have one thing in common. They’re in the healthcare sector and they all produce medical devices.

While the healthcare sector has hardly moved in the last 90 days, the same can’t be said for some of its serious out-performers:

Company 3 month outperformance
REVA Medical Inc (ASX: RVA) 47.57%
Airxpanders Inc (ASX: AXP) 32.94%
Ellex Medical Lasers Limited (ASX: ELX) 20.46%
Cochlear Limited (ASX: COH) 18.91%
Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) 16.75%


Reva Medical Inc

Reva is a medical device company located in San Diego, California. It’s focused on developing bioresorbable stents, which are called “scaffolds” because of their temporary nature. Scaffolds provide restoration of blood flow, support the artery through the healing process, then disappear from the body over a period of time.

AirXpanders Inc

Breast cancer is the second leading cause of death in women globally. In the US alone, there are approximately 300,000 new diagnoses of female breast cancer every year, 36% of early-stage patients and 60% of late-stage patients receive a mastectomy.

AirXpanders is a US-based company that produces AeroForm tissue expander for breast reconstruction following mastectomy.

Ellex Medical Lasers

Ellex Medical Lasers is an Australian based company that produces lasers and diagnostic equipment for the treatment of various stages of blindness and eye disease.

I could go into a whole bunch of explanations about what their laser technology does, terms like capsulotomy, photocoagulation, vitreous strands, opacities, and eye cubed diagnostics but, all you need to know is they have 20,000 lasers and ultrasound systems around the world being used to fight blindness and eye disease.

Cochlear Limited

Everyone’s heard of Cochlear. They make implants for the hearing impaired. The company offers three main products. Cochlear implants, baha bone conduction implants, and wireless accessories:

  • Cochlear implants are a device for people with moderate to profound hearing loss
  • Baha bone conduction implants are a device for people with conductive hearing loss, mixed hearing loss and single-sided deafness
  • Cochlear wireless accessories help users to explore sound without the constraints of wires and bulky components

Fisher & Paykel Healthcare

Fisher & Paykel Healthcare is a New Zealand-based company that produces devices for use in respiratory care, acute care and the treatment of obstructive sleep apnea.

Fisher & Paykel’s respiratory and acute care devices include respiratory humidifiers and obstructive sleep solutions such as Continuous Positive Airway Pressure (CPAP) devices, masks and humidifiers.

If healthcare shares are not your thing, here's a new breed of blue chips that could take your portfolio higher in 2016:

Forget BHP and Woolworths. These 3 "new breed" top blue chips for 2016 pay fully franked dividends and offer the very real prospect of significant capital appreciation. Click here to learn more.

The report is free! No credit card required.

Motley Fool contributor John Hopkins has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.